TENX übertreffen die 20 der letzten 37Schätzungen.
54%
Nächster Bericht
Datum des nächsten Berichts
23. März 2026
Estimate forQ4 25(Revenue/ EPS)
--
/
-$0.42
Implizierte Änderung vonQ3 25(Revenue/ EPS)
--
/
+5.00%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
--
/
+133.33%
Tenax Therapeutics, Inc. earnings per share and revenue
On 12. Nov. 2025, TENX reported earnings of -0.40 USD per share (EPS) for Q3 25, missing the estimate of -0.31 USD, resulting in a -25.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.42 USD, with revenue projected to reach -- USD, implying an increase of 5.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Tenax Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Tenax Therapeutics, Inc. reported EPS of -$0.40, missing estimates by -25.47%, and revenue of $0.00, 0% as expectations.
How did the market react to Tenax Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved down -4.29%, changed from $6.99 before the earnings release to $6.69 the day after.
When is Tenax Therapeutics, Inc. expected to report next?
The next earning report is scheduled for 23. März 2026.
What are the forecasts for Tenax Therapeutics, Inc.'s next earnings report?
Based on 7
analysts, Tenax Therapeutics, Inc. is expected to report EPS of -$0.42 and revenue of -- for Q4 2025.